Skip to main content
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.36
+0.27 (3.34%)
At close: Dec 20, 2024, 4:00 PM
8.50
+0.14 (1.67%)
After-hours: Dec 20, 2024, 7:57 PM EST

KalVista Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
150
Market Cap
413.13M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 202012.69M-3.44M-21.31%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.55B
Enhabit 1.04B
Akebia Therapeutics 169.88M
Arcturus Therapeutics Holdings 160.40M
National Research 144.16M
Alpha Teknova 36.35M
Nano-X Imaging 10.68M
Allogene Therapeutics 43.00K
Revenue Rankings

KALV News

More News